Bladder cancer epidemiology and demographics

Revision as of 20:22, 11 June 2014 by Rim Halaby (talk | contribs)
Jump to navigation Jump to search

Bladder cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bladder cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Electrocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bladder cancer epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bladder cancer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bladder cancer epidemiology and demographics

CDC on Bladder cancer epidemiology and demographics

Bladder cancer epidemiology and demographics in the news

Blogs on Bladder cancer epidemiology and demographics

Directions to Hospitals Treating Bladder cancer

Risk calculators and risk factors for Bladder cancer epidemiology and demographics

Steven C. Campbell, M.D., Ph.D.; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [1]

Overview

In the United States, bladder cancer is the fourth most common type of cancer in men and the ninth most common cancer in women. More than 47,000 men and 16,000 women are diagnosed with bladder cancer each year. One reason for its higher incidence in men is that the androgen receptor, which is much more active in men than in women, plays a major part in the development of the cancer.[1]

Epidemiology and Demographics

Prevalence

  • In the United States, the age-adjusted prevalence of (insert disease name here) is 0.1305% in 2011.[2]

Incidence

  • The delay-adjusted incidence of (insert disease name here) in 2011 was estimated to be 20.74 per 100,000 persons in the United States.[2]
  • In 2011, the age-adjusted incidence of (insert disease name here) was 20.13 per 100,000 persons in the United States.[2]

Age

  • While the overall age-adjusted incidence of (insert disease name here) in the United States between 2007 and 2011 is 20.5 per 100,000, the age-adjusted incidence of (insert disease name here) by age category is:[2]
    • Under 65 years: 5.4 per 100,000
    • 65 and over: 124.7 per 100,000

Gender

  • In the United States, the age-adjusted prevalence of (insert disease name here) by gender in 2011 is:[2]
    • In males: 0.2289%
    • In females: 0.0566%
  • In the United States, the delay-adjusted incidence of (insert disease name here) by gender in 2011 is:[2]
    • In males: 36.24 per 100,000 persons
    • In females: 8.98 per 100,000 persons
  • In the United States, the age-adjusted incidence of (insert disease name here) by gender on 2011 is:[2]
    • In males: 35.18 per 100,000 persons
    • In females: 8.72 per 100,000 persons
  • Shown below is an image depicting the delay-adjusted incidence and observed incidence of (insert disease name here) by gender and race in the United States between 1975 and 2011. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.[2]

[Insert figure x.1 from the report]

Race

  • Shown below is a table depicting the age-adjusted prevalence of (insert disease name here) by race in 2011 in the United States.[2]
All Races White Black Asian/Pacific Islander Hispanic
Age-adjusted prevalence 0.1305% 0.1482% 0.0620% 0.0587% 0.0644%
  • In the United States, the race that is most susceptible to developing this disease/condition, is the ____ race.[2]
  • Shown below is an image depicting the incidence of (insert disease name here) by race in the United States between YEAR and YEAR.[2]

[Insert figure x.2 from the report]

API: Asian/Pacific Islander; AI/AN: American Indian/ Alaska Native

References

  1. "Scientists Find One Reason Why Bladder Cancer Hits More Men". University of Rochester Medical Center. April 20 2007. Unknown parameter |is who want kill others accessdate= ignored (help); Check date values in: |date= (help)
  2. 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

Template:WH Template:WS